N-of-One Expands Executive Team to Meet Market Demand

  • Posted by 3mediaweb
  • On December 9, 2014
  • 0 Comments
– Experienced senior executives enable N-of-One to proactively support expanding base of large clients – LEXINGTON, Mass., December 9, 2014 – N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced the appointment of two senior executives to support the company’s rapid growth. The market for N-of-One’s clinical interpretation is exploding, […]
Read More

N-of-One Selected by NeoGenomics to Provide Clinical Evidence for Interpreting Solid Tumor Next-Generation Sequencing Tests

  • Posted by 3mediaweb
  • On December 2, 2014
  • 0 Comments
– Rapidly growing lab empowers oncologists with actionable precision medicine insights – LEXINGTON, Mass., December 2, 2014 – N-of-One, Inc. , the leader in clinical interpretation for precision medicine in oncology, today announced an agreement with NeoGenomics, Inc., a leading provider of cancer-focused genetic and molecular testing services. Under this agreement, N-of-One will provide clinical […]
Read More
BACK TO
TOP
LEARN
MORE